Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.40 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9004261 | 0.86 | HDAC4 (0.42) | HDAC4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2589110 | 0.80 | SLC6A2 (0.47) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL18611832 | 0.75 | HDAC4 (0.41) | HDAC4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1666028 | 0.73 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28465330 | 0.72 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL944385 | 0.71 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4379605 | 0.70 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL10601663 | 0.70 | HDAC4 (0.38) | HDAC4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28866366 | 0.70 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9797247 | 0.69 | HDAC4 (0.48) | HDAC4SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140362335-A1 | POLYMER-DOPED VERTICALLY-ALIGNED NEMATIC LIQUID CRYSTALS | LC VISION, LLC (US) | 2014-12-11 | — | — | US | disclosed |
| US-8834742-B2 | Polymer-doped vertically-aligned nematic liquid crystals | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-09-16 | — | — | US | disclosed |
| US-8778223-B2 | Liquid crystals having cyclohexyl core structures and fluorinated tails | LC VISION, LLC (US) | 2014-07-15 | — | — | US | disclosed |
| US-20120326083-A1 | LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS | LC VISION, LLC | 2012-12-27 | — | — | US | disclosed |
| US-20120105791-A1 | POLYMER-DOPED VERTICALLY-ALIGNED NEMATIC LIQUID CRYSTALS | NATIONAL SCIENCE FOUNDATION | 2012-05-03 | — | — | US | disclosed |
| WO-2012016130-A2 | POLYMER-DOPED VERTICALLY-ALIGNED NEMATIC LIQUID CRYSTALS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2012-02-02 | — | — | WO | disclosed |
| EP-0571916-B1 | A liquid crystal composition and a liquid crystal display containing it | CHISSO CORP (JP) | 1996-10-02 | — | — | EP | disclosed |
| EP-0656412-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE MADE THEREFROM | CHISSO CORPORATION (JP) | 1995-06-07 | — | — | EP | disclosed |
| US-5358662-A | Mixture; cyano-free | CHISSO CORPORATION (JP) | 1994-10-25 | — | — | US | disclosed |
| EP-0571916-A1 | A liquid crystal composition and a liquid crystal display containing it | Chisso Corporation (JP) | 1993-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120326083-A1 | LIQUID CRYSTALS HAVING CYCLOHEXYL CORE STRUCTURES AND FLUORINATED TAILS | Q6ZSR9, CRACR2A, RCC1 | HDAC4 3520/4885SLC6A2 3036/4885SLC6A4 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.